Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactide-co-glycolide), via an alternate class I MHC processing pathway

Archives of Pharmacal Research

Volumn 30, Issue 11, 2007, Pages 1440-1446

  Gerelchuluun, Turmunkh ^a   Lee, Young Hee ^a   Lee, Young Ran ^a   Im, Sun A ^a   Song, Sukgil ^a   Jeong, Sook Park ^a   Han, Kun ^a   Kim, Kyungjae ^b   Lee, Chong Kil ^a  

^a Chungbuk National University   (South Korea)

^b Sahmyook University   (South Korea)

Author keywords

Brefeldin A; Chloroquine; Cross presentation; Dendritic cell; Lactacystin; PLGA nanosphere

Indexed keywords

EID: 36849051370     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977369     Document Type: Article

References (28)

1. Ackerman, A. L. and Cresswell, P., Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol., 5, 678-684 (2004).
2. Bachmann, M. F., Oxenius, A., Pircher, H., Hengartner, H., Ashton-Richardt, P. A., Tnegawa, S., and Zinkernagel, R. M., TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol., 25, 1739-1749 (1995).
3. Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., and Heath, W. R., Inductionof a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ cell help. J. Exp. Med., 186, 65-70 (1997).
4. Bevan, M. J., Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med., 143, 1283-1288 (1976).
5. Campbell, D. J., Serwold, T., and Shastri, N., Bacterial proteins can be processed by macrophages in a transporter associated with antigen precessing-independent cysteine protease-dependent manner for presentation by MHC class I molecules. J. Immunol., 164, 168-175 (2000).
6. Chefalo, P. J., Grandea, A. G., Kaer, L. V., and Harding, C. V., Tapasin -/- and TAP-/- macrophages are deficient in vacuolar alternative class I MHV (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol., 170, 5825-5833 (2003).
7. Day, P. M., Esquivel, F., Lukszo, J., Bennink, R., and Yewdell, J. W., Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity, 2, 137-147 (1995).
8. Groothuis, T. A. and Neefjes, J., The many roads to cross-presentation. J. Exp. Med., 202, 1313-1318 (2005).
9. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol., 20, 621-667 (2002).
10. Harding, C. V. and Song, R., Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol., 153, 4925-4933 (1994).
11. Harding, C. V., Phagocytic processing of antigens for presentation by MHC molecules. Trend. Cell. Biol., 5, 105-108 (1995).
12. Harding, C. V., France, J., Song, R., Rarah, J. M., Chatterjee, S., Iqbal, M., and Siman, R., Novel dipeptide aldehydes are proteosome inhibitors and block the MHC-I antigen processing pathway.J. Immunol., 155, 1767-1775 (1995).
13. Heath, W. R. and Carbone, F. R., Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol., 1, 126-134 (2001).
14. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264, 961-965 (1994).
15. Karttunen, J., Sanderson, S., and Shastri, N., Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci., 89, 6020-6024 (1992).
16. Kovacsovics-Bankowski, M. and Rock, K. L., A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science, 267, 243-246 (1995).
17. Lee, Y. R., Yang, I. H., Lee, Y. H., Im, S. A., Song, S., Li, H., Han, K., Kim, K., Eo, S. K., and Lee, C. K., Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood, 105, 3951-3955 (2005).
18. Nixon, D. F., Hioe, C., Chen, P. D., Bian, Z., Kuebler, P., Li, M. L., Qiu, H., Li, X. M., Singh, M., Richardson, J., McGee, P., Zamb, T., Koff, W., Wang, C. Y., and O'Hagan, D., Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine, 14, 1523-1530 (1996).
19. Nuchtern, J. G., Bonifacine, J. S., Biddison, W. E., and Klausner, R. D., Brefeldin A implicates egress from endoplasmic reticulum in class I-restricted antigen presentation. Nature, 339, 223-226 (1989).
20. Ojcius, D. M., Gapin, L., and Kourilsky, P., Dissociation of the peptide/MHC class I complex: pH dependence and effect of endogenous peptides on the activation energy. Biochem. Biophys. Res. Commun., 197, 1216-1222 (1993).
21. Partidos, C. D., Vohra, P., Jones, D., Farrar, G., and Steward, M. W., CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J. Immunol. Methods., 206, 143-151 (1997).
22. Potter, S. P. and Harding, C. V., Neutrophil process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J. Immunol., 167, 2538-2546 (2001).
23. Raychaudhuri, S. and Rock, K. L., Fully mobilizing host defense: Building better vaccines. Nat. Biotech., 16, 1025-1031 (1998).
24. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L., Inhibitors pf proteosome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 78, 761-771 (1994).
25. Shen, Z., Reznikoff, G., Dranoff, G., and Rock, K. L., Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol., 158, 2723-2730 (1997).
26. Sigal, L. J., Crotty, S., Andino, R., and Rock, K. L., Cytotoxic T-cell immunity to virus-infected non-hematopoietic cells requires presentation of exogenous antigen. Nature, 398, 77-80 (1999).
27. Song, R., Porgador, A., and Harding C. V., Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens. Immunology, 97, 316-324 (1999).
28. Yewdell, J. W. and Bennink, J. R., Brefeldin A specifically inhibit presentation of protein antigens to cytotoxic T lymphocytes. Science, 244, 1072-1075 (1989).